4//SEC Filing
Hudson Leslie 4
Accession 0000873303-10-000044
CIK 0000873303other
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 12:48 PM ET
Size
19.5 KB
Accession
0000873303-10-000044
Insider Transaction Report
Form 4
Hudson Leslie
Other
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2010-07-26−60,118→ 0 totalExercise: $1.45From: 2011-02-09Exp: 2020-02-09→ Common Stock (60,118 underlying) - Exercise/Conversion
Common Stock
2010-07-26$1.45/sh+68,965$99,999→ 453,524 total - Sale
Common Stock
2010-07-26$1.90/sh−82,000$155,800→ 427,559 total - Sale
Common Stock
2010-07-26$1.92/sh−100$192→ 409,559 total - Exercise/Conversion
Common Stock
2010-07-26$1.45/sh+60,118$87,171→ 513,642 total - Sale
Common Stock
2010-07-26$1.89/sh−4,083$7,717→ 509,559 total - Sale
Common Stock
2010-07-26$1.91/sh−17,900$34,189→ 409,659 total - Sale
Common Stock
2010-07-26$1.92/sh−25,000$48,000→ 384,559 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2010-07-26−68,965→ 0 totalExercise: $1.45From: 2011-02-09Exp: 2020-02-09→ Common Stock (68,965 underlying)
Holdings
- 366,972
Incentive Stock Option (right to buy)
Exercise: $1.09From: 2009-02-08Exp: 2018-02-08→ Common Stock (366,972 underlying)
Footnotes (3)
- [F1]This transaction is a part of a Same Day Sale Transaction. The optionholder exercised his options and sold the shares on the same day.
- [F2]On 2/09/2010, the Company granted two options: an ISO of 531,035 and NQ of 68,965 for a total grant of 600,000 options. The combined option's original vesting terms were 200,000 vesting annually over 3 years. On 4/20/2010, the option had no vested shares and the Company accelerated the entire 600,000 options.
- [F3]Option Grant vests 25% per year on grant date with all shares vesting four years from date of grant.
Documents
Issuer
AVI BIOPHARMA INC
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001321265
Filing Metadata
- Form type
- 4
- Filed
- Jul 27, 8:00 PM ET
- Accepted
- Jul 28, 12:48 PM ET
- Size
- 19.5 KB